1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. RemeGen Co., Ltd.
  6. Financials
    9995   CNE1000048G6

REMEGEN CO., LTD.

(9995)
  Report
Delayed Hong Kong Stock Exchange  -  11:43 2022-08-17 pm EDT
49.75 HKD   -2.74%
08/03RemeGen to Purchase $4.4 Million of Wealth Management Products
MT
07/22RemeGen to Purchase Wealth Management Products from Qingdao Bank for $11.8 Million
MT
07/05RemeGen Invests $14 Million in Wealth Management Products
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2020 2021 2022 2023 2024
Capitalization1 39 16631 09228 437--
Enterprise Value (EV)2 36 59529 38726 04126 64826 828
P/E ratio -56,1x111x-23,3x-77,1x222x
Yield -----
Capitalization / Revenue -21,8x29,9x13,4x9,93x
EV / Revenue -20,6x27,4x12,5x9,37x
EV / EBITDA -60,4x80,3x-31,2x-186x164x
Price to Book 10,9x8,98x5,09x5,33x5,00x
Nbr of stocks (in thousands) 489 837489 837539 197--
Reference price (CNY) 80,063,544,244,244,2
Announcement Date 03/26/202102/20/2022---
1 HKD in Million
2 CNY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 --1 4269502 1292 863
EBITDA1 --606366-834-143164
Operating profit (EBIT)1 --669282-1 025-39012,4
Operating Margin --19,7%-108%-18,3%0,43%
Pre-Tax Profit (EBT)1 --698276-1 004-32994,4
Net income1 -430-698276-1 004-33756,0
Net margin --19,4%-106%-15,8%1,96%
EPS2 --1,420,57-1,90-0,570,20
Dividend per Share2 ------
Announcement Date 10/28/202003/26/202102/20/2022---
1 CNY in Million
2 CNY
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 S2
Net sales1 1 397
EBITDA -
Operating profit (EBIT) -
Operating Margin -
Pre-Tax Profit (EBT)1 720
Net income -
Net margin -
EPS -
Dividend per Share -
Announcement Date 02/20/2022
1 CNY in Million
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 ------
Net Cash position1 -2 5711 7042 3961 7891 609
Leverage (Debt / EBITDA) -4,24x-4,66x2,87x12,5x-9,82x
Free Cash Flow1 --1 104--1 066-447-119
ROE (Net Profit / Equities) --41,5%7,85%-21,7%-7,49%2,81%
Shareholders' equity1 -1 6813 5214 6234 4931 994
ROA (Net Profit / Asset) --29,0%6,68%-17,1%-3,25%1,39%
Assets1 -2 4034 1385 86710 3614 035
Book Value Per Share2 -7,347,078,688,298,85
Cash Flow per Share2 --1,62--1,24-0,160,84
Capex1 -443-464442298
Capex / Sales ---48,8%20,8%10,4%
Announcement Date 10/28/202003/26/202102/20/2022---
1 CNY in Million
2 CNY
Estimates
Key data
Capitalization (HKD) 32 891 791 083
Capitalization (USD) 4 193 600 305
Net sales (CNY) 1 426 360 700
Net sales (USD) 210 346 660
Number of employees 2 121
Sales / Employee (CNY) 672 494
Sales / Employee (USD) 99 173
Free-Float 50,5%
Free-Float capitalization (HKD) 16 615 623 420
Free-Float capitalization (USD) 2 118 439 925
Avg. Exchange 20 sessions (CNY) 70 221 757
Avg. Exchange 20 sessions (USD) 10 355 664
Average Daily Capital Traded 0,21%
EPS & Dividend